Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model.
Ke YaoXin LiangGuiyang ZhangYan RongQiuxiang ZhangQiaobo LiaoHong ZhangKai XiJunming WangPublished in: Polymers (2022)
COF may act as both an RGC protection agent and a carrier for prolonged rapamycin release. This research may lead to the development of novel RGC protection agents and drug delivery techniques, as well as the creation of multifunctional COF-based biomaterials for glaucoma retinopathy.